Evaluation of symptoms and symptom combinations in histamine intolerance

Wolfgang J. Schnedl; Sonja Lackner; Dietmar Enko; Michael Schenk; Sandra J. Holasek; Harald Mangge

doi:10.5217/ir.2018.00152

Articles

Page Path: HOME > Intest Res > Volume 17(3); 2019 > Article

Original Article Functional bowel disorders Evaluation of symptoms and symptom combinations in histamine intolerance: Wolfgang J. Schnedl^1,, Sonja Lackner², Dietmar Enko³, Michael Schenk⁴, Sandra J. Holasek⁵, Harald Mangge; Intestinal Research 2019;17(3):427-433.
DOI: https://doi.org/10.5217/ir.2018.00152
Published online: March 7, 2019

¹Practice for General Internal Medicine, Bruck, Austria

²Institute of Pathophysiology, Otto Loewi Research Centre, Medical University of Graz, Graz, Austria

³Institute of Laboratory Medicine, General Hospital Steyr, Steyr, Austria

⁴Das Kinderwunsch Institut Schenk GmbH, Dobl, Austria

⁵Clinical Institute of Medical and Chemical Laboratory Diagnosis, Medical University of Graz, Graz, Austria

Correspondence to Wolfgang J. Schnedl, Practice for General Internal Medicine, Theodor Körnerstrasse 19b, A-8600 Bruck/Mur, Austria. Tel: +43- 3612-55833, Fax: +43-3612-55833-22, E-mail: w.schnedl@dr-schnedl.at

• Received: November 13, 2018 • Revised: January 18, 2019 • Accepted: February 6, 2019

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next

15,933 Views
546 Download
47 Web of Science
55 Crossref
48 Scopus

Full Article

Download PDF

Abstract
INTRODUCTION
METHODS
RESULTS
DISCUSSION
NOTES
REFERENCES

Abstract

Background/Aims
Food intolerance/malabsorption, particularly histamine intolerance (HIT), may cause nonspecific functional gastrointestinal and extraintestinal symptoms. We evaluated gastrointestinal and extraintestinal symptoms in patients with HIT.
Methods
In an analysis of outpatients’ charts we identified 133 patients, who presented with recurring nonspecific functional gastrointestinal, extraintestinal symptoms, and a diamine oxidase value <10 U/mL, indicative of HIT. A standardized anonymous questionnaire with symptoms of HIT based on known symptoms and the 4 histamine receptors including gastrointestinal, cardiovascular, respiratory and skin complaints was developed, and sent by mail to the patients.
Results
In the 62 patients that completed the questionnaire, bloating was the most common and most serious symptom. Other commonly reported gastrointestinal symptoms were postprandial fullness, diarrhea, abdominal pain, and constipation. The presence of 2 from a list of 24 symptoms resulted in 276 various symptom combinations. From calculated 2.024 possible combinations of 3 symptoms the patients with HIT presented 1.975 combinations.
Conclusions
The knowledge of this wide variability of symptoms and complex symptom combinations in patients with HIT may help to clinically recognize and diagnose HIT.
Keywords: Diamine oxidase; Histamine; Irritable bowel syndrome; Gluten; Gastrointestinal diseases

INTRODUCTION

Food intolerance/malabsorption syndromes are reported in up to 20% of the population in westernized countries and, particularly histamine intolerance (HIT) may cause nonspecific GI complaints and extraintestinal symptoms [1]. In HIT a disproportionate amount of histamine in the body is thought to result from the consumption of food with high histamine content, and a reduced ability of mainly the enzyme diamine oxidase (DAO) to digest histamine [2]. The clinical diagnosis of HIT is challenging and the symptoms may occur according to the known 4 receptors of histamine [3]. Here, we describe various symptoms and complex symptom combinations in patients with HIT. This may help to clinically recognize and diagnose HIT.

METHODS

In a retrospective analysis of outpatients’ charts, we identified 133 patients (male:female, 30:103; median age, 39 years; age range, 18–81 years), who presented with recurring functional nonspecific abdominal complaints and who had a DAO value <10 U/mL (median, 5.8 U/mL; range, 1.5–9.9 U/mL). In our outpatient setting we decided to include serum DAO determination in the evaluation of patients who present with recurring functional nonspecific abdominal complaints [4]. A thorough anamnesis, concerning abdominal complaints and a timely relation to ingestion of histamine-containing food or drinks, including pharmaceutical treatments which might influence HIT, was performed. All of the patients were examined for and did not show lactose intolerance, fructose malabsorption, Helicobacter pylori infection or celiac disease.

A registered dietician was consulted to introduce and observe, using a food diary, a histamine-elimination diet for 2 weeks. If the patients were free of or had noteworthy improvement of GI symptoms, together with a DAO value <10 U/mL at first presentation, then the diagnosis of HIT was established [5]. All patients received written information about HIT and the dietician helped to develop an individually tailored long-time diet to ensure nutritional adequacy and to provide sustained relief.

In the morning, at the first presentation, blood drawings were performed after overnight fasting (>12 hours) and determination of DAO in serum was made with a radio extraction assay (Sciotec Diagnostic Technologies, Tulln, Austria) within 3 days. We used hydrogen (H₂) breath tests for exclusion of lactose intolerance and fructose malabsorption (Gastrolyzer; Bedfont Scientific Inc., Kent, England). Either histologic evaluation of gastric mucosa or an enzyme-linked IgA immunosorbent assay (ELISA; Serion, Würzburg, Germany) were done and showed absence of H. pylori infection. For screening of celiac disease antibodies against tissue transglutaminase were determined with anti-tTG IgA ELISA (Euro-Diagnostica AB, Malmö, Sweden). All patients >50 years old were screened by colonoscopy and no pathology was present. None of the patients showed signs of infection.

A standardized anonymous questionnaire, regarding symptoms the patients experienced before the diagnosis of HIT and/or what complaints they have due to ingesting foods with high histamine content, was established. This questionnaire was based on known symptoms and the 4 histamine receptors according to the literature [2,3], and it was sent by mail to the patients. Every questionnaire listed 23 symptoms in 4 categories including GI, cardiovascular, respiratory and skin complaints, and for every symptom a severity score from 0 (no symptoms) to 5 (very intense) was included. Space was provided for patients to add other symptoms. Of 133 selected patients 69 (51.9%) returned the questionnaire, but 7 envelopes were returned unopened. Therefore, 62 questionnaires (46.6%) were included in this anonymous evaluation.

Qualitative data are presented as absolute and relative frequencies; quantitative parameters are summarized as mean and SD or, median and interquartile range (IQR) according to distribution, respectively. Data distribution was assessed by the Shapiro-Wilk test and the severity of symptoms is stated as the median of the reported symptom severities. Statistical analyses were performed with SPSS version 23.0 (IBM Corp., Armonk, NY, USA) and R version 3.4.2 (R Core Team, Vienna, Austria) was used to determine the frequency of combinations of symptoms. Written informed consent was obtained from each patient included in the study. The study conforms to the ethical guidelines of the Declaration of Helsinki and was approved by the Ethical Committee of the Johannes Kepler University in Linz, Austria (approval No. K-107-16).

RESULTS

Bloating was the most common symptom among these patients (92%) and was observed as the most severe symptom with a severity score of 4 (Table 1). Other common HIT-related GI symptoms included: postprandial fullness (73%), diarrhea (71%), abdominal pain (68%), and constipation (55%) as shown in Fig. 1. Eighteen patients (29%) added other symptoms in the space provided (burning sensation in mouth, on tongue, or anus, migraine, shaking-heavy legs, weakness, leg edema, listlessness, fatigue, insomnia, reduced power of concentration, heartburn, dry skin, ophthalmitis, anxiety, suffocating, sore throat, hoarseness, cardiac arrhythmia, and arterial hypertension) and assigned them a high symptom severity score of 4. Two of these patients added 2 other symptoms.

According to the symptom categories, all the GI symptoms were mentioned most frequently, followed by cardiovascular symptoms. The presence of 2 of the 24 symptoms in all 4 categories resulted in 276 various combinations. Of the GI symptom combinations, bloating was the most frequent in combination with other GI symptoms, and 115 various combinations were reported to occur in more than 25% of patients (Table 2).

Two patients showed only 3 or fewer symptoms, but 96.8% of patients with HIT presented with more than 3 symptoms. The median of the number of symptoms was 10 (IQR, 7), and the mean value was 11.1 symptoms (SD, ± 4.8). Less than 10 symptoms were indicated by 40.3% of patients, 14.5% of patients had 10 symptoms and 45.2% showed more than 10 symptoms (Fig. 2). From the calculated 2.024 possible combinations of 3 symptoms, patients presented with 1.975 combinations, and only 49 combinations were not displayed. From the 10.626 possible combinations of 4 symptoms, 9.899 combinations were presented and 727 combinations did not occur.

DISCUSSION

HIT is assumed to be due to a GI-DAO deficit and the name was created with reference to the term lactose intolerance. A disproportionate amount of histamine in the body is thought to result from the consumption of food with high histamine content, and a reduced ability of mainly the enzyme DAO to digest histamine [6]. The clinical diagnosis of HIT is challenging but patients with low serum DAO values, 2 or more GI symptoms described for HIT, and a reduction of symptoms due to a histamine-reduced diet may be diagnosed with HIT [4,5]. In the present study we describe the wide variability of GI, extraintestinal and combinations of symptoms associated with HIT. Polymorphisms identified for the genes coding for DAO and for histamine receptors may help explain these symptoms [7,8]. Complex symptom combinations may influence disease expression and the individual response to diets or treatments.

Disorders such as IBS are one of the main reasons for consultation in primary care and IBS is associated with high symptom burden causing a reduced quality of life. The diagnosis of IBS solely relies on self-reported symptoms by patients, and is in many cases self-diagnosed and self-treated [9]. Currently Rome IV criteria as classification and diagnostic criteria in IBS are used but they have limitations in clinical practice since many patients do not demonstrate the required criteria. In Rome IV the recurring symptom of abdominal pain with change in bowel habits, including diarrhea, constipation, bloating and distension, was described as main IBS symptom [10]. We here found bloating to be the most frequent and most severe symptom in HIT. Frequently, patients also reported postprandial fullness, diarrhea, abdominal pain and constipation which resemble IBS-linked symptoms. However, IBS patients were shown to believe that food, including histamine-containing food, triggers their GI symptoms [11].

Another new, symptom-based disorder is non-celiac gluten sensitivity (NCGS) and it is associated with the consumption of gluten-containing products [12]. Since there are no diagnostic criteria available for NCGS they are also referred to as “people without celiac disease avoiding gluten.” [13] It was assumed that people with NCGS are a group of patients with IBS who are self-diagnosed and perform self-treatment with a gluten-free diet [14]. However most gluten-containing foods and drinks also contain histamine and/or they are consumed with added histamine-containing seasonings. We described that GI and extraintestinal symptoms in NCGS resemble those which can be found in HIT [15].

Functional dyspepsia (FD) is a disorder with a heterogeneous group of symptoms in the epigastric region and again, with absence of any organic disease. For FD a number of explanations was employed but pathophysiology is unknown and despite all attempts the treatment of FD remains insufficient [16]. Abdominal pain and postprandial fullness are described in FD as main symptoms [17] and patients with HIT reported these also to be prominent symptoms (Table 2).

However, a symptom is an experience observed as different from normal and depends very much on the individual patients’ subjective interpretation. Symptoms alone or symptom complexes are rarely, if ever, diagnostic [9]. Although, included patients experienced recurring symptoms caused by food ingestion with high histamine content, in this study a recall bias cannot be entirely excluded. So far, no laboratory values have been found to correlate with symptoms in IBS, NCGS, or FD. Although, serum DAO values are not fully established to reflect GIDAO activity [1] and determination of DAO in serum with currently available assays has limitations [18], the diagnosis of HIT may be supported with measurements of serum DAO [4,5].

Since there are symptom correlations and parallels in IBS, NCGS, and FD with HIT, determination of serum DAO values in well-defined patients with recurring functional non-specific GI symptoms in IBS, NCGS, and FD are necessary. In conclusion, the knowledge of this wide and complex variability of symptoms in patients with HIT may assist clinically recognizing and diagnosing histamine intolerance.

NOTES

FINANCIAL SUPPORT

The authors received no financial support for the research, authorship, and/or publication of this article.

CONFLICT OF INTEREST

W.J.S. received speaking honoraria from Sciotec. The other authors declare no competing interests.

AUTHOR CONTRIBUTION

Study design: Schnedl WJ, Enko D, Mangge H. Patient recruitment and data collection: Schnedl WJ. Laboratory data determination: Schenk M, Mangge H. Data analysis: Schnedl WJ, Lackner S, Holasek SJ. Discussion of results: Schnedl WJ, Schenk M, Holasek SJ, Mangge H. Writing the manuscript: Schnedl WJ, Lackner S, Enko D. Approval of final manuscript: all authors.

Fig. 1.

Frequency and distribution of symptoms in patients with histamine intolerance.

Fig. 2.

Number of symptom combinations in patients with histamine intolerance.

Table 1.

Symptom Severity Score in Patients with Histamine Intolerance

Symptom	Symptom severity score
Bloating	4
Abdominal pain, intestinal colic, diarrhea, postprandial fullness, dysmenorrhea, flush, belching, palpitations, rhinorrhea	3
Constipation, pruritus	2.5
Nausea, emesis, rash, swollen reddened eye lids, headache, dizziness, nose congestion, sneezing, dyspnea	2
Hypotonia	1.5
Collapse	1

Score will range 0 (no symptoms) to 5 (very intense). None of the symptoms was indicated with a symptom severity code 5.

Table 2.

Most Common Combinations of 2 Symptoms in Patients with Histamine Intolerance

Symptom combinations	Percent of patients	Symptom combinations	Percent of patients
Bloating - postprandial fullness	69	Diarrhea - nausea	42
		Diarrhea - nose congestion
		Diarrhea - sneezing
		Dizziness - constipation
		Dizziness - intestinal colic
		Dizziness - palpitation
		Bloating - palpitation
		Postprandial fullness - intestinal colic
		Postprandial fullness - nose congestion
		Abdominal pain - nose congestion
Bloating - diarrhea	66	Diarrhea - intestinal colic	40
Bloating - abdominal pain		Headache - intestinal colic
		Headache - nausea
		Postprandial fullness - nausea
		Abdominal pain - nausea
Bloating - dizziness	63	Diarrhea - constipation	39
Bloating - headache		Diarrhea - palpitation
		Diarrhea - pruritus
		Diarrhea - belching
		Dizziness - belching
		Dizziness - nausea
		Headache - constipation
		Abdominal pain - belching
		Abdominal pain - rhinorrhea
		Abdominal pain - sneezing
Abdominal pain - dizziness	55	Dizziness - nose congestion	37
		Dizziness - pruritus
		Dizziness - sneezing
		Headache - belching
		Headache - nose congestion
		Postprandial fullness - constipation
		Postprandial fullness - sneezing
		Postprandial fullness - pruritus
		Abdominal pain - palpitation
Postprandial fullness - abdominal pain	53	Constipation - intestinal colic	35
Bloating - intestinal colic		Dizziness - rhinorrhea
		Headache - palpitation
		Headache - pruritus
		Postprandial fullness - rhinorrhea
Diarrhea - dizziness	52	Abdominal pain - pruritus	34
Bloating-belching		Intestinal colic - nausea
		Intestinal colic - nose congestion
		Intestinal colic - sneezing
		Rhinorrhea - sneezing
Diarrhea - headache	50	Intestinal colic - belching	32
Diarrhea - abdominal pain		Intestinal colic - rhinorrhea
Dizziness - headache		Bloating - flush
Bloating - constipation		Bloating - hypotonia
Postprandial fullness - diarrhea		Belching - sneezing
Postprandial fullness - headache		Postprandial fullness - palpitation
		Pruritus - nose congestion
		Pruritus - sneezing
		Headache - rhinorrhea
		Headache - sneezing
		Rhinorrhea - nose congestion
Bloating - nose congestion	48	Constipation - palpitation	31
Bloating - rhinorrhea		Nausea - belching
		Nausea - nose congestion
		Nausea - sneezing
		Belching - pruritus
		Postprandial fullness - flush
		Postprandial fullness - hypotonia
		Pruritus - palpitation
		Pruritus - rhinorrhea
		Palpitation - nose congestion
Bloating - nausea	47	Diarrhea - flush	29
Bloating - pruritus		Nausea - pruritus
Bloating - sneezing		Belching - nose congestion
Postprandial fullness - dizziness		Flush - headache
Abdominal pain - headache		Nose congestion - sneezing
Abdominal pain - intestinal colic
Diarrhea - rhinorrhea	45	Intestinal colic - pruritus	27
Postprandial fullness - belching		Intestinal colic - palpitation
		Bloating - dysmenorrhea
		Bloating - other symptoms
		Constipation - belching
		Constipation - nose congestion
		Nausea - rhinorrhea
		Belching - rhinorrhea
		Dizziness - hypotonia
		Palpitation - sneezing
Abdominal pain - constipation	44	Abdominal pain - dysmenorrhea	26
		Abdominal pain - hypotonia
		Diarrhea - swollen, reddened eyelids
		Belching - hypotonia
		Belching - palpitation
		Pruritus - flush
		Headache - hypotonia
		Palpitation - rhinorrhea

REFERENCES

1. Reese I, Ballmer-Weber B, Beyer K, et al. German guideline for the management of adverse reactions to ingested histamine: guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Association of Allergologists (AeDA), and the Swiss Society for Allergology and Immunology (SGAI). Allergo J Int 2017;26:72–79.Article PubMed PMC PDF
2. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr 2007;85:1185–1196.Article PubMed PDF
3. Jones BL, Kearns GL. Histamine: new thoughts about a familiar mediator. Clin Pharmacol Ther 2011;89:189–197.Article PubMed
4. Mušič E, Korošec P, Šilar M, Adamič K, Košnik M, Rijavec M. Serum diamine oxidase activity as a diagnostic test for histamine intolerance. Wien Klin Wochenschr 2013;125:239–243.Article PubMed PDF
5. Lackner S, Malcher V, Enko D, Mangge H, Holasek SJ, Schnedl WJ. Histamine-reduced diet and increase of serum diamine oxidase correlating to diet compliance in histamine intolerance. Eur J Clin Nutr 2019;73:102–104.Article PubMed PDF
6. Kovacova-Hanuskova E, Buday T, Gavliakova S, Plevkova J. Histamine, histamine intoxication and intolerance. Allergol Immunopathol 2015;43:498–506.Article
7. Maintz L, Yu CF, Rodríguez E, et al. Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities. Allergy 2011;66:893–902.Article PubMed
8. Sadek B, Stark H. Cherry-picked ligands at histamine receptor subtypes. Neuropharmacology 2016;106:56–73.Article PubMed
9. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA 2015;313:949–958.Article PubMed
10. Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil 2017;23:151–163.Article PubMed PMC PDF
11. Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013;108:634–641.Article PubMed PDF
12. Newberry C, McKnight L, Sarav M, Pickett-Blakely O. Going gluten free: the history and nutritional implications of today’s most popular diet. Curr Gastroenterol Rep 2017;19:54.Article PubMed PDF
13. Choung RS, Unalp-Arida A, Ruhl CE, Brantner TL, Everhart JE, Murray JA. Less hidden celiac disease but increased gluten avoidance without a diagnosis in the United States: findings from the National Health and Nutrition Examination Surveys from 2009 to 2014. Mayo Clin Proc 2017;92:30–38.Article
14. De Giorgio R, Volta U, Gibson PR. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut 2016;65:169–178.Article PubMed
15. Schnedl WJ, Lackner S, Enko D, Schenk M, Mangge H, Holasek SJ. Non-celiac gluten sensitivity. People without celiac disease avoiding gluten: is it due to histamine intolerance? Inflamm Res 2018;67:279–284.Article PubMed PDF
16. Holtmann G, Shah A, Morrison M. Pathophysiology of functional gastrointestinal disorders: a holistic overview. Dig Dis 2017;35:5–13.Article
17. Talley NJ. Functional dyspepsia: new insights into pathogenesis and therapy. Korean J Intern Med 2016;31:444–456.Article PubMed PMC PDF
18. Boehm T, Pils S, Gludovacz E, et al. Quantification of human diamine oxidase. Clin Biochem 2017;50:444–451.Article PubMed

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Exploring the Relationship between Diamine Oxidase and Psychotropic Medications in Fibromyalgia Treatment, Finding No Reduction in Diamine Oxidase Levels and Activity except with Citalopram
Yaiza Tobajas, Marc Alemany-Fornés, Iris Samarra, Jordi Romero-Giménez, Jordi Cuñé-Castellana, Maria Tintoré, Antoni del Pino, Núria Canela, Josep M. del Bas, Nàdia Ortega-Olivé, Carlos de Lecea, Xavier Escoté
Journal of Clinical Medicine.2024; 13(3): 792. CrossRef
Nahrungsmittelallergie und Histaminintoleranz
Yurdagül Zopf, Walburga Dieterich
Die Gastroenterologie.2024; 19(1): 3. CrossRef
Prevalence and Clinical Picture of Diamine Oxidase Gene Variants in Children and Adolescents with Attention Deficit Hyperactivity Disorder: A Pilot Study
Hilario Blasco-Fontecilla, Marcos Bella-Fernández, Ping Wang, Marina Martin-Moratinos, Chao Li
Journal of Clinical Medicine.2024; 13(6): 1659. CrossRef
Histamine intolerance
Martin Fuchs
Medicína pro praxi.2024; 21(1): 18. CrossRef
Pilot Study on the Prevalence of Diamine Oxidase Gene Variants in Patients with Symptoms of Histamine Intolerance
Adriana Duelo, Oriol Comas-Basté, Sònia Sánchez-Pérez, M. Teresa Veciana-Nogués, Eva Ruiz-Casares, M. Carmen Vidal-Carou, M. Luz Latorre-Moratalla
Nutrients.2024; 16(8): 1142. CrossRef
Histamine Intolerance: Symptoms, Diagnosis, and Beyond
Christoph Jochum
Nutrients.2024; 16(8): 1219. CrossRef
Histamin İntoleransına Güncel Bakış
Yeşim Öztekin
İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi.2024; (22): 446. CrossRef
A Novel Herbal Composition Alleviates Functional Constipation, Reduces Gastrointestinal Transit Time, and Improves Bowel Function in Adults: A Double-Blind, Randomized Clinical Study
Gaurav Singh, Indresh Dixit, Douglas Kalman, Naga Tejaswi Gogineni
Journal of the American Nutrition Association.2024; 43(6): 553. CrossRef
Nutritional Implications of Mast Cell Diseases
Cheryl Iny Harris, Bonnie Nasar, Celeste C. Finnerty
Journal of the Academy of Nutrition and Dietetics.2024;[Epub] CrossRef
The Factors Influencing the Concentration of Histamine in Jarred Baby Foods Containing Fish, Considering Evaluation of Daily Histamine Intake
Marta Buczkowska, Anna Szczyrba, Dominika Szajnoga, Michał Górski, Jolanta Malinowska-Borowska, Joanna Domagalska, Piotr Rozentryt
Journal of Food Protection.2024; 87(9): 100328. CrossRef
A pathophysiological perspective on wine induced headaches
Greta Stołecka, Mateusz Sydor, Paulina Kalemba, Konrad Kochman, Robert Iwanowski, Paweł Iwaszkiewicz
Medical Journal of Cell Biology.2024; 12(3): 101. CrossRef
Trans-ε-viniferin as an inhibitor of TMEM16A preventing intestinal smooth muscle contraction
Xin-Yi Liu, Yan Zhao, Ling-Ling Jin, Yue Pang, Bo Yu
Journal of Asian Natural Products Research.2023; 25(9): 867. CrossRef
Focus on histamine production during cheese manufacture and processing: A review
Maria Carmela Ferrante, Raffaelina Mercogliano
Food Chemistry.2023; 419: 136046. CrossRef
Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study
Gülşah Okutan, Teresa Perucho Alcalde, Eva Ruiz Casares, Bruno F. Penadés, Guerthy Melissa Sánchez Niño, Ana Terrén Lora, Sara López Oliva, Lorena Torrente Estríngana, Adriana Duelo, Ismael San Mauro Martín
Frontiers in Genetics.2023;[Epub] CrossRef
Food Fermentation Technology: Examples of application in Malaysian Foods
Genevie Eleanor Ruby, Noor Azira Abdul Mutalib, Nurul Hanisah Juhari, Ungku Fatimah Ungku Zainal Abidin
Food and Humanity.2023; 1: 32. CrossRef
Histamine intolerance and irritable bowel syndrome
Yu.A. Golubeva, A.F. Sheptulina, O.M. Drapkina
Profilakticheskaya meditsina.2023; 26(6): 130. CrossRef
Functional Abdominal Pain Disorders in Children May Be Associated with Food Intolerance/Malabsorption
Wolfgang J. Schnedl, Michael Schenk, Simon Michaelis, Dietmar Enko, Harald Mangge
Children.2023; 10(9): 1444. CrossRef
Resistant potato starch supplementation reduces serum histamine levels in healthy adults with links to attenuated intestinal permeability
Jason R. Bush, Jun Han, Edward C. Deehan, Scott V. Harding, Madhura Maiya, Joshua Baisley, David Schibli, David R. Goodlett
Journal of Functional Foods.2023; 108: 105740. CrossRef
Placebo-Controlled Histamine Challenge Disproves Suspicion of Histamine Intolerance
Rebekka Karolin Bent, Claudia Kugler, Valentina Faihs, Ulf Darsow, Tilo Biedermann, Knut Brockow
The Journal of Allergy and Clinical Immunology: In Practice.2023; 11(12): 3724. CrossRef
Exogenous Supplementation with DAO Enzyme in Women with Fibromyalgia: A Double-Blind Placebo-Controlled Clinical Trial
Gülşah Okutan, Guerthy Melissa Sánchez Niño, Ana Terrén Lora, Sara López Oliva, Ismael San Mauro Martín
Journal of Clinical Medicine.2023; 12(20): 6449. CrossRef
Diet of the 21st-century person — food intolerances and elimination diets
Ewa Gacoń
Health Promotion & Physical Activity.2023; 23(2): 21. CrossRef
Health concerns associated with biogenic amines in food and interaction with amine oxidase drugs
Bruno M Dala-Paula, Flávia B Custódio, Maria BA Gloria
Current Opinion in Food Science.2023; 54: 101090. CrossRef
Myths and Facts about Food Intolerance: A Narrative Review
Fabiana Zingone, Luisa Bertin, Daria Maniero, Michela Palo, Greta Lorenzon, Brigida Barberio, Carolina Ciacci, Edoardo Vincenzo Savarino
Nutrients.2023; 15(23): 4969. CrossRef
Diamine Oxidase Interactions with Anti-Inflammatory and Anti-Migraine Medicines in the Treatment of Migraine
Yaiza Tobajas, Marc Alemany-Fornés, Iris Samarra, Jordi Romero-Giménez, Maria Tintoré, Antoni del Pino, Núria Canela, Josep M. del Bas, Nàdia Ortega-Olivé, Carlos de Lecea, Xavier Escoté
Journal of Clinical Medicine.2023; 12(23): 7502. CrossRef
Nachblutung bei Septorhinoplastik
Olaf Michel
HNO Nachrichten.2023; 53(6): 35. CrossRef
Intolerancia alimentaria
Mauricio Colella, Claudio Alberto Salvador Parisi
Revista Alergia México.2023; 70(4): 265. CrossRef
Diagnóstico diferencial en alergia alimentaria
Liziane Nunes de Castilho Santos
Revista Alergia México.2023; 70(4): 260. CrossRef
Food allergy and hypersensitivity reactions in children and adults—A review
Sandra G. Tedner, Anna Asarnoj, Helena Thulin, Marit Westman, Jon R. Konradsen, Caroline Nilsson
Journal of Internal Medicine.2022; 291(3): 283. CrossRef
Histamine Intolerance—A Kind of Pseudoallergic Reaction
Ying Zhao, Xiaoyan Zhang, Hengxi Jin, Lu Chen, Jiang Ji, Zhongwei Zhang
Biomolecules.2022; 12(3): 454. CrossRef
Food intolerances and the small intestine
Asfold I. Parfenov
Terapevticheskii arkhiv.2022; 94(2): 153. CrossRef
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study
Valentina Cucca, Giuseppe A. Ramirez, Patrizia Pignatti, Chiara Asperti, Marco Russo, Emanuel Della-Torre, Daniela Breda, Samuele E. Burastero, Lorenzo Dagna, Mona-Rita Yacoub
Nutrients.2022; 14(7): 1513. CrossRef
Intestinal Dysbiosis in Patients with Histamine Intolerance
Sònia Sánchez-Pérez, Oriol Comas-Basté, Adriana Duelo, M. Teresa Veciana-Nogués, Mercedes Berlanga, M. Luz Latorre-Moratalla, M. Carmen Vidal-Carou
Nutrients.2022; 14(9): 1774. CrossRef
Serum Diamine Oxidase Values, Indicating Histamine Intolerance, Influence Lactose Tolerance Breath Test Results
Wolfgang J. Schnedl, Nathalie Meier-Allard, Simon Michaelis, Sonja Lackner, Dietmar Enko, Harald Mangge, Sandra J. Holasek
Nutrients.2022; 14(10): 2026. CrossRef
WITHDRAWN: Elevated histamine etiology model for most major vaccine associated adverse events including SARS-CoV-2 spike vaccines
Darrell O. Ricke
Medical Hypotheses.2022; : 110893. CrossRef
Histamine intolerance (HIT)
Joanna Matysiak
Journal of Medical Science.2022; : e727. CrossRef
The dietary treatment of histamine intolerance reduces the abundance of some histamine-secreting bacteria of the gut microbiota in histamine intolerant women. A pilot study
Sònia Sánchez-Pérez, Oriol Comas-Basté, Adriana Duelo, M. Teresa Veciana-Nogués, Mercedes Berlanga, M. Carmen Vidal-Carou, M. Luz Latorre-Moratalla
Frontiers in Nutrition.2022;[Epub] CrossRef
Advances in the Clinical Application of Histamine and Diamine Oxidase (DAO) Activity: A Review
Zhaowang Tan, Yingwei Ou, Wenwei Cai, Yueliang Zheng, Hengjie Li, Yunyun Mao, Shengang Zhou, Jianfeng Tu
Catalysts.2022; 13(1): 48. CrossRef
Improvement of digestive symptoms in fibromyalgia patients following a diet modification according to histamine release test – an observational study
Jose Gomez-Arguelles, Oscar Caceres, Manuel Blanco, Ceferino Maestu, Francisco Martin
Rheumatology.2022; 60(3): 209. CrossRef
Considering histamine in functional gastrointestinal disorders
Wolfgang J. Schnedl, Dietmar Enko
Critical Reviews in Food Science and Nutrition.2021; 61(17): 2960. CrossRef
Non-responsive celiac disease may coincide with additional food intolerance/malabsorption, including histamine intolerance
Wolfgang J. Schnedl, Harald Mangge, Michael Schenk, Dietmar Enko
Medical Hypotheses.2021; 146: 110404. CrossRef
Histamine accumulation in dairy products: Microbial causes, techniques for the detection of histamine‐producing microbiota, and potential solutions
Marta Moniente, Diego García‐Gonzalo, Ignacio Ontañón, Rafael Pagán, Laura Botello‐Morte
Comprehensive Reviews in Food Science and Food Safety.2021; 20(2): 1481. CrossRef
Histamine Intolerance Originates in the Gut
Wolfgang J. Schnedl, Dietmar Enko
Nutrients.2021; 13(4): 1262. CrossRef
Low-Histamine Diets: Is the Exclusion of Foods Justified by Their Histamine Content?
Sònia Sánchez-Pérez, Oriol Comas-Basté, M. Teresa Veciana-Nogués, M. Luz Latorre-Moratalla, M. Carmen Vidal-Carou
Nutrients.2021; 13(5): 1395. CrossRef
Histamine Intolerance in Children: A Narrative Review
Wojciech Nazar, Katarzyna Plata-Nazar, Katarzyna Sznurkowska, Agnieszka Szlagatys-Sidorkiewicz
Nutrients.2021; 13(5): 1486. CrossRef
Food Allergy and Intolerance: A Narrative Review on Nutritional Concerns
Domenico Gargano, Ramapraba Appanna, Antonella Santonicola, Fabio De Bartolomeis, Cristiana Stellato, Antonella Cianferoni, Vincenzo Casolaro, Paola Iovino
Nutrients.2021; 13(5): 1638. CrossRef
Food Intolerance: The Role of Histamine
Yulia O. Shulpekova, Vladimir M. Nechaev, Irina R. Popova, Tatiana A. Deeva, Arthur T. Kopylov, Kristina A. Malsagova, Anna L. Kaysheva, Vladimir T. Ivashkin
Nutrients.2021; 13(9): 3207. CrossRef
The cold chain and the COVID-19 pandemic: an unusual increase in histamine content in fish samples collected in Southern Italy during lockdown
Francesco Giuseppe Galluzzo, Gaetano Cammilleri, Antonello Cicero, Licia Pantano, Andrea Pulvirenti, Andrea Macaluso, Nicola Cicero, Vittorio Calabrese, Vincenzo Ferrantelli
Food Quality and Safety.2021;[Epub] CrossRef
Comparing histamine intolerance and non-clonal mast cell activation syndrome
Nevio Cimolai
Intestinal Research.2020; 18(1): 134. CrossRef
Lyophilised legume sprouts as a functional ingredient for diamine oxidase enzyme supplementation in histamine intolerance
Oriol Comas-Basté, M. Luz Latorre-Moratalla, Judit Rabell-González, M. Teresa Veciana-Nogués, M. Carmen Vidal-Carou
LWT.2020; 125: 109201. CrossRef
Histamine Intolerance: The Current State of the Art
Oriol Comas-Basté, Sònia Sánchez-Pérez, Maria Teresa Veciana-Nogués, Mariluz Latorre-Moratalla, María del Carmen Vidal-Carou
Biomolecules.2020; 10(8): 1181. CrossRef
Increasing Expiratory Hydrogen in Lactose Intolerance Is Associated with Additional Food Intolerance/Malabsorption
Wolfgang J. Schnedl, Nathalie Meier-Allard, Sonja Lackner, Dietmar Enko, Harald Mangge, Sandra J. Holasek
Nutrients.2020; 12(12): 3690. CrossRef
Interdisciplinary Significance of Food-Related Adverse Reactions in Adulthood
Dóra Solymosi, Miklós Sárdy, Györgyi Pónyai
Nutrients.2020; 12(12): 3725. CrossRef
Vegetal diamine oxidase alleviates histamine-induced contraction of colonic muscles
Armelle Tchoumi Neree, Rodolphe Soret, Lucia Marcocci, Paola Pietrangeli, Nicolas Pilon, Mircea Alexandru Mateescu
Scientific Reports.2020;[Epub] CrossRef
Diamine oxidase supplementation improves symptoms in patients with histamine intolerance
Wolfgang J. Schnedl, Michael Schenk, Sonja Lackner, Dietmar Enko, Harald Mangge, Florian Forster
Food Science and Biotechnology.2019; 28(6): 1779. CrossRef
Food Intolerances
Caroline J Tuck, Jessica R Biesiekierski, Peter Schmid-Grendelmeier, Daniel Pohl
Nutrients.2019; 11(7): 1684. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Evaluation of symptoms and symptom combinations in histamine intolerance

Intest Res. 2019;17(3):427-433. Published online March 7, 2019

DOI: https://doi.org/10.5217/ir.2018.00152

XML Download

Figure

Evaluation of symptoms and symptom combinations in histamine intolerance

Fig. 1. Frequency and distribution of symptoms in patients with histamine intolerance.

Fig. 2. Number of symptom combinations in patients with histamine intolerance.

Fig. 1.

Fig. 2.

Evaluation of symptoms and symptom combinations in histamine intolerance

Symptom	Symptom severity score
Bloating	4
Abdominal pain, intestinal colic, diarrhea, postprandial fullness, dysmenorrhea, flush, belching, palpitations, rhinorrhea	3
Constipation, pruritus	2.5
Nausea, emesis, rash, swollen reddened eye lids, headache, dizziness, nose congestion, sneezing, dyspnea	2
Hypotonia	1.5
Collapse	1

Symptom combinations	Percent of patients	Symptom combinations	Percent of patients
Bloating - postprandial fullness	69	Diarrhea - nausea	42
		Diarrhea - nose congestion
		Diarrhea - sneezing
		Dizziness - constipation
		Dizziness - intestinal colic
		Dizziness - palpitation
		Bloating - palpitation
		Postprandial fullness - intestinal colic
		Postprandial fullness - nose congestion
		Abdominal pain - nose congestion
Bloating - diarrhea	66	Diarrhea - intestinal colic	40
Bloating - abdominal pain		Headache - intestinal colic
		Headache - nausea
		Postprandial fullness - nausea
		Abdominal pain - nausea
Bloating - dizziness	63	Diarrhea - constipation	39
Bloating - headache		Diarrhea - palpitation
		Diarrhea - pruritus
		Diarrhea - belching
		Dizziness - belching
		Dizziness - nausea
		Headache - constipation
		Abdominal pain - belching
		Abdominal pain - rhinorrhea
		Abdominal pain - sneezing
Abdominal pain - dizziness	55	Dizziness - nose congestion	37
		Dizziness - pruritus
		Dizziness - sneezing
		Headache - belching
		Headache - nose congestion
		Postprandial fullness - constipation
		Postprandial fullness - sneezing
		Postprandial fullness - pruritus
		Abdominal pain - palpitation
Postprandial fullness - abdominal pain	53	Constipation - intestinal colic	35
Bloating - intestinal colic		Dizziness - rhinorrhea
		Headache - palpitation
		Headache - pruritus
		Postprandial fullness - rhinorrhea
Diarrhea - dizziness	52	Abdominal pain - pruritus	34
Bloating-belching		Intestinal colic - nausea
		Intestinal colic - nose congestion
		Intestinal colic - sneezing
		Rhinorrhea - sneezing
Diarrhea - headache	50	Intestinal colic - belching	32
Diarrhea - abdominal pain		Intestinal colic - rhinorrhea
Dizziness - headache		Bloating - flush
Bloating - constipation		Bloating - hypotonia
Postprandial fullness - diarrhea		Belching - sneezing
Postprandial fullness - headache		Postprandial fullness - palpitation
		Pruritus - nose congestion
		Pruritus - sneezing
		Headache - rhinorrhea
		Headache - sneezing
		Rhinorrhea - nose congestion
Bloating - nose congestion	48	Constipation - palpitation	31
Bloating - rhinorrhea		Nausea - belching
		Nausea - nose congestion
		Nausea - sneezing
		Belching - pruritus
		Postprandial fullness - flush
		Postprandial fullness - hypotonia
		Pruritus - palpitation
		Pruritus - rhinorrhea
		Palpitation - nose congestion
Bloating - nausea	47	Diarrhea - flush	29
Bloating - pruritus		Nausea - pruritus
Bloating - sneezing		Belching - nose congestion
Postprandial fullness - dizziness		Flush - headache
Abdominal pain - headache		Nose congestion - sneezing
Abdominal pain - intestinal colic
Diarrhea - rhinorrhea	45	Intestinal colic - pruritus	27
Postprandial fullness - belching		Intestinal colic - palpitation
		Bloating - dysmenorrhea
		Bloating - other symptoms
		Constipation - belching
		Constipation - nose congestion
		Nausea - rhinorrhea
		Belching - rhinorrhea
		Dizziness - hypotonia
		Palpitation - sneezing
Abdominal pain - constipation	44	Abdominal pain - dysmenorrhea	26
		Abdominal pain - hypotonia
		Diarrhea - swollen, reddened eyelids
		Belching - hypotonia
		Belching - palpitation
		Pruritus - flush
		Headache - hypotonia
		Palpitation - rhinorrhea

Table 1. Symptom Severity Score in Patients with Histamine Intolerance

Score will range 0 (no symptoms) to 5 (very intense). None of the symptoms was indicated with a symptom severity code 5.

Table 2. Most Common Combinations of 2 Symptoms in Patients with Histamine Intolerance